Articles From: Douglas Dynamics, Inc. to Release Second Quarter 2014 Results and Host Conference Call to Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements


MILWAUKEE, July 24, 2014 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE:PLOW) , the North American leader in the design, manufacture and sale of snow and ice control equipment for light trucks, today announced that it will release financial results for the second quarter ended June 30, 2014, after the close of the market on Monday, August 4 th , 2014.
Sign-up for Douglas Dynamics, Inc. to Release Second Quarter 2014 Results and Host Conference Call investment picks
Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced that it has signed agreements to upsize its existing senior loan facility with ABN AMRO Bank N.V., Nordea Bank Finland Plc, and Skandinaviska Enskilda Banken AB ("SEB"). The total amount available under the facility has been increased by $53 million to $225 million.
Sign-up for Ardmore Shipping Completes Debt Financing for Three Recent Acquisitions investment picks
Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced that the Company plans to announce its second quarter 2014 earnings before the market opens on Tuesday, July 29, 2014 and will host a conference call later in the day at 10:00 a.m. Eastern Time.
Sign-up for Ardmore Shipping Announces Second Quarter 2014 Conference Call and Webcast investment picks
Fluor Corporation (NYSE: FLR) announced today that the Directorate-General for Public Works and Water Management of the Netherlands Rijkswaterstaat has announced its intention to appoint IXAS Zuid-Oost, a consortium consisting of Fluor, Ballast Nedam, Heijmans and 3i Infrastructure plc, as the selected bidder for the public-private-partnership (PPP) project A9 Gaasperdammerweg in the Netherlands.
Sign-up for IXAS Zuid-Oost, a Consortium Consisting of Fluor, Ballast Nedam, Heijmans and 3i Infrastructure, Selected as Preferred Bidder for the Project A9 Gaasperdammerweg in the Netherlands investment picks
2014/7/24
Casablanca Capital LP, (“Casablanca”) the beneficial owner of approximately 5.2% of Cliffs Natural Resources (“Cliffs”) shares, today urged its fellow Cliffs shareholders to disregard Glass Lewis’s last minute reversal of its recommendation to vote for Casablanca’s GOLD card.
Sign-up for Casablanca Urges Cliffs Shareholders to Vote GOLD Card to Ensure Urgent and Necessary Change is Implemented investment picks
2014/7/24
By Erin McCarthy American Airlines Group Inc. said it posted the highest quarterly profit in the company's history, as its second-quarter revenue also surged.
Sign-up for American Airlines profit climbs, unveils capital plan investment picks
2014/7/24
BALTIMORE , July 24, 2014 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on BioCorRx, Inc. (OTCQB – BICX). The healthcare solutions company is on the leading edge of substance abuse addiction treatment.
Sign-up for Goldman Small Cap Research Issues Research Report on BioCorRx Inc. investment picks
Meridian Bioscience, Inc. (NASDAQ: VIVO) today: reported fiscal 2014 third quarter and first nine months net sales of $47.2 million and $142.1 million, respectively, flat and an increase of 2%, respectively, from the same periods of the prior fiscal year; reported third quarter operating income of $13.1 million, a decrease of 16% from the same period of the prior fiscal year; reported nine months operating income of $40.4 million, a decrease of 8% from the same period of the prior fiscal year; reported third quarter net earnings of $8.8 million, or $0.21 per diluted share, decreases of 13% compared to the fiscal 2013 third quarter; reported first nine months net earnings of $26.6 million, or $0.63 per diluted share, decreases of 8% and 9%, respectively, compared to the
Sign-up for Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance investment picks
YuMe, Inc. (NYSE: YUME), a leading provider of digital video brand advertising solutions, today announced that it will release second quarter 2014 financial results after the market closes on Wednesday, August 13.
Sign-up for YuMe to Report Second Quarter Financial Results on August 13 investment picks
HAMPTON, Va., July 24, 2014 (GLOBE NEWSWIRE) -- Measurement Specialties, Inc. (Nasdaq:MEAS) , (the "Company"), a global designer and manufacturer of sensors and sensor-based systems, held the grand opening of their new West China R&D and Manufacturing Center in Chengdu today.
Sign-up for Measurement Specialties Opens New Greenfield Facility in Chengdu investment picks
Dover Downs Gaming & Entertainment, Inc. (NYSE: DDE) today reported results for the three months ended June 30, 2014.
Sign-up for Dover Downs Gaming & Entertainment, Inc. Reports Results for the Second Quarter Ended June 30, 2014 investment picks
Dover Motorsports, Inc. (NYSE: DVD) today reported results for the three months ended June 30, 2014.
Sign-up for Dover Motorsports, Inc. Reports Results for the Second Quarter of 2014 investment picks
2014/7/24
ATLANTA , July 24, 2014 /PRNewswire/ -- Gray Television, Inc. ("Gray" or "we" or "our") (NYSE: GTN and GTN.A) announced today that it has agreed to acquire WJRT-TV and WTVG-TV from affiliates of SJL Holdings, LLC ("SJL") for approximately $128.0 million in cash.
Sign-up for Gray To Acquire ABC Affiliate In Flint, Michigan, And ABC/CW Affiliate In Toledo, Ohio From SJL Holdings investment picks
8x8, Inc. (NASDAQ:EGHT), a provider of cloud-based unified communications, contact center and collaboration solutions, today announced the availability of a new, out-of-the-box integration with Zendesk’s customer service platform that enhances the Customer Experience Management capabilities of the 8x8 Virtual Office cloud telephony and unified communications (UC) platform.
Sign-up for 8x8 Extends Partnership With Zendesk to Enhance Customer Experience Management With the Virtual Office Cloud Telephony Platform investment picks
2014/7/24
Active International Equity Specialist with Close to US$10 billion in AUM BALTIMORE , July 24, 2014 /PRNewswire/ -- Legg Mason (NYSE:LM) today announced the acquisition of Martin Currie, an active international equity specialist based in the United Kingdom.
Sign-up for Legg Mason Announces Acquisition Of Martin Currie investment picks
NEW YORK (MarketWatch) -- Valeant Pharmaceuticals International Inc. (VRX) said Thursday it has filed an official and detailed complaint with the Canadian regulator, Autorite des Marches Financiers, about statements made by Allergan Inc. (AGN) regarding Valeant's business.
Sign-up for Valeant files official complaint about Allergan with Canadian regulator investment picks
PETALUMA, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , today announced that the financial results for its fiscal first quarter 2015, ended June 30, 2014, will be released after the U.S. markets close on August 7, 2014.
Sign-up for Oculus Innovative Sciences Announces Fiscal First Quarter 2015 Financial Results and Conference Call investment picks
Materion Corporation (NYSE:MTRN) today reported second quarter financial results.
Sign-up for Materion Corporation Reports Second Quarter Financial Results Revises Full-Year Guidance investment picks
- Patent will protect MYOS' intellectual property portfolio for Fortetropin through 2033 – CEDAR KNOLLS, N.J., July 24, 2014 (GLOBE NEWSWIRE) -- MYOS Corporation ("MYOS" or the "Company") (Nasdaq:MYOS) , an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, announced today that it recently received a Notice of Allowance from the U.S. Patent and Trademark Office ("USPTO") for U.S. Patent Application Serial No.
Sign-up for MYOS Corporation Receives Notice of Allowance of U.S. Patent Application for Proprietary Manufacturing Methods of Fortetropin investment picks
2014/7/24
Argent Energy Trust announces higher than expected second quarter production and provides operational update Canada NewsWire Note regarding barrel of oil equivalency Barrels of oil equivalent (boe) may be misleading, particularly if used in isolation.
Sign-up for Argent Energy Trust announces higher than expected second quarter production and provides operational update investment picks
Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers, today announced dosing of the first patient in its Phase 2 clinical study of ETC-1002 in patients with hypercholesterolemia and hypertension, ETC-1002-014.
Sign-up for Esperion Therapeutics Announces Initiation of a Phase 2 Clinical Study of ETC-1002 in Patients with Hypercholesterolemia and Hypertension investment picks
ATLANTA , July 24, 2014 /PRNewswire/ -- Second Quarter and Recent Highlights: Appointed Pat Mackin as President and Chief Executive Officer effective September 2, 2014 Product revenues grew 12 percent year-over-year to $20.4 million BioGlue ® revenues grew 14 percent year-over-year to $15.3 million PerClot ® revenues grew 22 percent year-over-year to $1.1 million HeRO ® Graft revenues grew 20 percent year-over-year to $1.7 million Tissue processing revenues decreased 6 percent year-over-year to $14.3 million CryoLife, Inc. (NYSE: CRY) , a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today its results for the second quarter and first six months of 2014.
Sign-up for CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million investment picks
2014/7/24
By MarketWatch 3M profit, sales rise in line with forecasts 3M(MMM)reported second-quarter net profit of $1.27 billion, or $1.91 a share, up from $1.2 billion, or $1.71 a share, a year ago.
Sign-up for Updates, advisories and surprises investment picks
The Board of Directors of Crestwood Equity GP LLC, general partner of Crestwood Equity Partners LP (NYSE:CEQP) (“Crestwood Equity”) announced that it has declared the partnership’s quarterly cash distribution of $0.1375 per limited partner unit ($0.55 annually) for the quarter ended June 30, 2014.
Sign-up for Crestwood Equity Partners Announces Quarterly Distribution and Conference Call Schedule investment picks
Connection to HIE will enable the exchange and use of critical patient data to improve outcomes CHICAGO and LITTLE ROCK, Ark.
Sign-up for Allscripts Connects to State of Arkansas HIE investment picks
GREENVILLE, S.C. , July 24, 2014 /PRNewswire/ -- KEMET Corporation (the "Company") (NYSE: KEM) , a leading global supplier of electronic components, today reported preliminary results for our first quarter ended June 30, 2014.
Sign-up for KEMET Reports Preliminary Fiscal 2015 First Quarter Results investment picks
Motorola Solutions Inc. (NYSE:MSI) is unveiling a new wireless local area network (WLAN) offering that is easy to manage and deploy without sacrificing best-in-class technology.
Sign-up for Motorola Solutions Unveils WiNG Express, Offering Small and Mid-size Businesses a High-performance Enterprise-class WLAN investment picks
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements Canada NewsWire LAVAL, Quebec , July 24, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE: AGN) apparent attempts to mislead investors and to negatively influence the market price of Valeant's common shares by continuing to make false and misleading statements regarding Valeant's business despite Valeant's public statements correcting this misinformation.
Sign-up for Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Douglas Dynamics, Inc. to Release Second Quarter 2014 Results and Host Conference Call to Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices